Avatar Health builds AI-powered digital twins that integrate multi-omic data, clinical phenotypes, and real-world signals to predict health trajectories and optimize interventions — transforming medicine from reactive to predictive.
86% of U.S. healthcare spending addresses chronic conditions that could have been detected years earlier. Avatar Health exists to close that gap — building the intelligence layer that identifies disease trajectories before clinical symptoms emerge.
A unified longitudinal patient model that ingests, normalizes, and integrates data from genomic, epigenomic, proteomic, metabolomic, microbiome, wearable, and clinical sources — continuously updated via streaming data.
AI-driven detection of multi-factor interaction effects — gene × microbiome × drug × lifestyle — that determine who responds to what, when, and why. Patterns invisible to single-variable analysis become actionable.
Predicted near-term and long-term risk pathways — not static risk scores. Forecasting health transition points across the aging continuum with 12- to 24-month intervention windows.
A continuous feedback loop that transforms health data into intelligence, intelligence into interventions, and interventions into measurable outcomes.
Multi-omic labs, wearables, EMR, imaging, environmental and lifestyle data unified through FHIR-compatible APIs.
Proprietary longevity ontology mapping biomarkers to hallmarks of aging, biological age models, and intervention-response patterns.
AI-driven trajectory models forecast transition points — metabolic, cardiovascular, cognitive, and immunological decline — before clinical presentation.
Responder stratification and protocol optimization match each individual to interventions with the highest predicted response probability.
Outcome data feeds back into the model. Every intervention response sharpens predictions for the entire cohort. The system gets smarter with every patient.
Avatar Health powers the data infrastructure and AI. Optimum Human is the consumer brand that puts precision health into people's hands.
The intelligence engine. Multi-omic data integration, digital twin generation, AI-driven trajectory modeling, and evidence-grade analytics for biopharma, payers, and clinical partners. The data moat that compounds with every patient.
The consumer platform. Personalized healthspan optimization through proactive biomarker monitoring, AI-driven protocols, and early disease detection. Subscription-based precision health that translates Avatar Health intelligence into actionable guidance for individuals.
Our platform maps the full complexity of human aging through a proprietary ontology that connects molecular, cellular, and functional data layers.
Genomics, epigenomics, proteomics, metabolomics, and microbiome data unified into a single patient model. Cross-layer correlations reveal interaction effects invisible in siloed analysis.
13 hallmarks of aging mapped to measurable biomarkers across 14 functional domains. Each hallmark tracked longitudinally with intervention-response correlation.
Weighted integration of epigenetic clock data, telomere length, inflammatory markers, metabolic biomarkers, proteomic age predictors, and functional capacity — continuously refined by longitudinal outcome data.
Pattern matching across multi-omic phenotypes and longitudinal cohort response data to generate rank-ordered protocol recommendations — identifying which interventions work for which individuals.
Enterprise-grade data governance with PHI encryption, role-based access, full audit trails, and FHIR R4 compatibility. Built for regulatory-grade evidence generation from day one.
CDISC/SDTM-compatible data standards and real-world evidence modules designed for biopharma partnerships, clinical trial enablement, and value-based care analytics.
The longevity economy, AI diagnostics, and precision medicine are converging into the largest healthcare transformation in a generation.
27+ years spanning molecular biology R&D through senior commercial leadership in precision medicine, genomics, and life sciences. From bench scientist at Life Technologies to building commercial organizations at QIAGEN, SOPHiA GENETICS, TwinStrand Biosciences, and NeoGenomics — with a career-long focus on translating scientific capability into commercial execution and clinical impact.
Whether you're a clinical partner, biopharma collaborator, investor, or an individual ready for precision health — we'd like to hear from you.